Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.
Market Cap
$2.77B
P/E Ratio
-18.4
1Y Stock Return
125.95%
1Y Revenue Growth
86.92%
Dividend Yield
0.00%
Price to Book
3.1
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Yahoo
WATERTOWN, Mass., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of small molecule medicines using targeted protein degradation (TPD), today announced that the Company will participate in fireside chats at the following upcoming investor events: Guggenheim Inaugural Healthcare Innovation Conference in Boston, MA on November 12 at 10:00 a.m. ET;J.P. Morgan Equity Opportunities Forum in Miami, FL on Novem
Yahoo
Last week, you might have seen that Kymera Therapeutics, Inc. ( NASDAQ:KYMR ) released its quarterly result to the...
SeekingAlpha
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q3 2024 Earnings Conference Call October 31, 2024 8:30 AM ETCompany ParticipantsJustine Koenigsberg - VP, IRNello...
Yahoo
Kymera Therapeutics ( NASDAQ:KYMR ) Third Quarter 2024 Results Key Financial Results Revenue: US$3.74m (down 21% from...
Yahoo
Kymera reports a narrower-than-expected loss in the third quarter. The company expects the current cash balance to provide a runway into mid-2027.
Yahoo
Kymera Therapeutics Inc (KYMR) showcases promising clinical progress and robust financial health, despite facing competitive challenges and strategic shifts.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NOC | -15.60% | $71.54B | +4.23% | 1.60% |
PGR | -15.11% | $149.10B | +57.29% | 0.45% |
LMT | -14.13% | $126.40B | +18.99% | 2.36% |
MCK | -13.20% | $78.15B | +35.51% | 0.42% |
PULM | -12.18% | $19.83M | +202.98% | 0.00% |
HUSA | -12.06% | $16.69M | -11.56% | 0.00% |
MNR | -11.06% | $1.66B | -10.71% | 15.90% |
ACGL | -10.92% | $36.00B | +16.84% | 0.00% |
RNR | -10.36% | $13.74B | +23.09% | 0.58% |
CME | -9.75% | $82.76B | +9.21% | 1.98% |
STG | -8.95% | $35.67M | +7.92% | 0.00% |
COR | -7.76% | $47.48B | +21.20% | 0.86% |
SU | -7.49% | $52.05B | +23.58% | 3.92% |
CYCN | -7.43% | $4.77M | -16.19% | 0.00% |
MVO | -7.26% | $106.15M | -22.78% | 16.78% |
TTE | -7.10% | $138.45B | -11.95% | 5.50% |
PRPO | -7.04% | $9.10M | -13.65% | 0.00% |
OXBR | -6.95% | $19.05M | +178.18% | 0.00% |
WHLM | -6.74% | $17.64M | -29.34% | 0.00% |
GIS | -6.38% | $34.85B | -2.91% | 3.78% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
KROS | 47.28% | $2.17B | +73.87% | 0.00% |
RXRX | 46.79% | $1.80B | -4.13% | 0.00% |
PRTA | 45.66% | $756.01M | -56.52% | 0.00% |
RVMD | 45.19% | $9.50B | +171.62% | 0.00% |
ACLX | 44.83% | $4.74B | +69.19% | 0.00% |
CRSP | 44.15% | $4.01B | -30.49% | 0.00% |
OPEN | 43.10% | $1.14B | -31.62% | 0.00% |
RCKT | 42.77% | $1.20B | -39.83% | 0.00% |
FOLD | 42.64% | $2.84B | -11.52% | 0.00% |
PGEN | 41.59% | $228.91M | -28.00% | 0.00% |
FATE | 41.39% | $248.29M | -11.02% | 0.00% |
ALEC | 41.13% | $377.04M | -19.46% | 0.00% |
QS | 41.01% | $2.54B | -13.31% | 0.00% |
CSV | 40.97% | $590.66M | +75.49% | 1.16% |
ARVN | 40.81% | $1.49B | +4.04% | 0.00% |
ATXS | 40.56% | $550.23M | +114.29% | 0.00% |
BEAM | 39.95% | $2.09B | -9.52% | 0.00% |
TWST | 39.84% | $2.42B | +74.27% | 0.00% |
FARO | 39.50% | $486.17M | +40.51% | 0.00% |
PRLB | 39.39% | $907.12M | +1.96% | 0.00% |
Current Value
$42.751 Year Return
Current Value
$42.751 Year Return
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NAT | -<0.01% | $636.83M | -30.05% | 13.79% |
EG | 0.01% | $15.92B | -8.98% | 2.02% |
NVGS | -0.03% | $1.12B | +8.76% | 1.24% |
NINE | -0.06% | $49.99M | -42.44% | 0.00% |
MSB | -0.07% | $337.71M | +30.73% | 5.15% |
GTE | 0.08% | $225.69M | -1.28% | 0.00% |
TR | -0.08% | $2.33B | -0.74% | 1.10% |
CIG.C | 0.09% | $2.48B | -3.55% | 0.00% |
HQY | 0.09% | $8.97B | +52.15% | 0.00% |
PRT | -0.15% | $48.72M | -16.56% | 10.33% |
XNET | 0.18% | $123.61M | +26.62% | 0.00% |
MODV | -0.18% | $222.68M | -59.06% | 0.00% |
LGF.B | 0.18% | $1.63B | -25.36% | 0.00% |
CANG | -0.20% | $253.50M | +212.50% | 0.00% |
TRV | 0.20% | $58.86B | +48.10% | 1.59% |
EOG | -0.21% | $76.03B | +10.19% | 2.70% |
RLMD | 0.22% | $89.92M | +1.36% | 0.00% |
NGL | 0.25% | $572.94M | +5.60% | 0.00% |
IMNN | -0.25% | $10.02M | -22.89% | 0.00% |
OCFT | -0.30% | $80.95M | -30.38% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
CLOI | 0.07% | $715.40M | 0.4% |
FTGC | 0.13% | $2.17B | 1.02% |
SOYB | 0.43% | $27.32M | 0.22% |
KRBN | -0.80% | $242.47M | 0.85% |
MINT | -0.87% | $11.62B | 0.35% |
DBMF | 0.97% | $1.02B | 0.85% |
CORN | 0.99% | $61.12M | 0.2% |
IXC | 1.13% | $2.20B | 0.41% |
AGZD | 1.34% | $142.76M | 0.23% |
HDRO | -1.56% | $164.26M | 0.3% |
JBBB | 1.61% | $1.26B | 0.49% |
BCI | 1.61% | $1.20B | 0.26% |
CSHI | 1.72% | $482.85M | 0.38% |
BILZ | -1.84% | $563.02M | 0.14% |
UNG | 2.15% | $908.80M | 1.06% |
GCC | 2.27% | $133.23M | 0.55% |
HIGH | -2.29% | $302.78M | 0.51% |
SGOV | 2.30% | $27.53B | 0.09% |
USCI | -2.57% | $185.47M | 1.07% |
FMF | -2.63% | $244.61M | 0.95% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
RSPA | 58.76% | $273.87M | 0% |
XBI | 55.71% | $6.58B | 0.35% |
ARKG | 52.61% | $1.13B | 0.75% |
GNOM | 51.12% | $70.59M | 0.5% |
IBB | 51.07% | $6.66B | 0.45% |
PTH | 50.48% | $143.31M | 0.6% |
IWC | 49.48% | $933.99M | 0.6% |
XPH | 47.69% | $157.87M | 0.35% |
IWO | 46.91% | $12.56B | 0.24% |
KOMP | 46.35% | $2.09B | 0.2% |
PBE | 46.23% | $258.53M | 0.58% |
ITEQ | 46.01% | $84.84M | 0.75% |
VO | 45.83% | $73.70B | 0.04% |
QQA | 45.77% | $135.01M | 0% |
IWM | 45.65% | $75.73B | 0.19% |
VTWO | 45.64% | $12.38B | 0.1% |
WCLD | 45.56% | $454.67M | 0.45% |
SMOT | 45.47% | $374.04M | 0.49% |
IMCG | 45.35% | $2.42B | 0.06% |
CLOU | 45.32% | $349.39M | 0.68% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -36.01% | $388.04M | 1.43% |
VIXY | -29.29% | $195.31M | 0.85% |
TAIL | -21.17% | $67.98M | 0.59% |
USDU | -14.87% | $201.97M | 0.5% |
TPMN | -12.27% | $40.60M | 0.65% |
UUP | -12.11% | $309.25M | 0.77% |
CTA | -12.04% | $350.27M | 0.78% |
XHLF | -7.31% | $874.27M | 0.03% |
DBO | -7.30% | $217.57M | 0.77% |
EQLS | -6.57% | $76.08M | 1% |
DBE | -6.18% | $50.13M | 0.77% |
KMLM | -5.38% | $353.87M | 0.9% |
BSCO | -5.01% | $2.35B | 0.1% |
COMT | -4.96% | $829.06M | 0.48% |
CANE | -4.93% | $17.72M | 0.29% |
KCCA | -4.78% | $220.51M | 0.87% |
GSG | -3.63% | $914.42M | 0.75% |
PDBC | -3.46% | $4.40B | 0.59% |
DBA | -3.38% | $755.88M | 0.93% |
DBC | -2.84% | $1.39B | 0.87% |